J&J’s $16.6B Deal for Abiomed Indicators a New Concentration on Medtech
Johnson & Johnson introduced an eye-popping health care-product enterprise acquisition early Tuesday, having to pay $16.6 billion upfront for Abiomed ...
Read moreJohnson & Johnson introduced an eye-popping health care-product enterprise acquisition early Tuesday, having to pay $16.6 billion upfront for Abiomed ...
Read moreEmail Contact: souhaib@trendswide.com